Topics

Patients with metastatic colorectal cancer harbouring certain BRAF mutations may respond to anti-EGFR therapy

10:40 EDT 13 Sep 2019 | ecancermedicalscience

Patients with metastatic colorectal cancer harbouring a subset of non-V600 mutations in the BRAF gene, known as class 3 BRAF mutations, were more likely to respond to anti-EGFR treatment according to a new study published in Clinical Cancer Research, a...

Original Article: Patients with metastatic colorectal cancer harbouring certain BRAF mutations may respond to anti-EGFR therapy

NEXT ARTICLE

More From BioPortfolio on "Patients with metastatic colorectal cancer harbouring certain BRAF mutations may respond to anti-EGFR therapy"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...